Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of vipor (P) in relapsed or refractory large B-cell lymphoma

Thomas Oellerich, Rebecca Wurm-Kuczera, Shashwat Sahay, Meng Wang, Salaheddine Ali, Nazli Serin, Khouloud Kouidri, Donika Tahiri, Sebastian Scheich, Uta Brunnberg, David Winkler, Samixa Pudasaini, Zoi Saxonis, Atef Abdelhafez, Tatiana Borodina, Ulrike Krueger, David Böckle, Corinna Leng, Joseph Kauer, Isabelle Krämer, Konstantinos Christofyllakis, Marcel Teichert, Niklas Gebauer, Ulf Schnetzke, Thomas Weber, Lukas Frenzel, Anna-Carina Hund, Evgenii Shumilov, Thomas Melchardt, Florian Eisele, Mirjeta Berisha, Jakob Rudzki, Christian Scholz, Martin Schmidt-Hieber, Dimitrios Mougiakakos, Johannes Duell, Gerald Wulf, Christian Schmidt, Georg Lenz, Bastian von Tresckow, Hans Christian Reinhardt, Richard Greil, Lorenz Thurner, Peter Dreger, Martin Dreyling, Christiane Pott, Martina Rudelius, Oliver Weigert, Phillipp Strubel, Roland Eils, Antonia Busse, Ulrich Keller, Naveed Ishaque, Björn Chapuy

Blood (2025) 146 (Supplement 1): 3688.

https://doi.org/10.1182/blood-2025-3688

Published: 2025

Journal Articles

The role of RhoA in diffuse large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 5308.

https://doi.org/10.1182/blood-2025-5308

Published: 2025

Journal Articles

Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes

Blood (2024) 144 (Supplement 1): 229.

https://doi.org/10.1182/blood-2024-204606

Published: 2024

Journal Articles

Characterizing the Microbiome-Immune Axis in Hematopoietic Stem Cell Recipients

Sabrina A. Becker, Julius C. Enssle, Anne C. Wilke, Sylvia Pfundt, Nico Zeltner, Ana Jankovic, Sebastian Wolf, Thomas A. Wichelhaus, Volkard A. J. Kempf, Maria J. G. T. Vehreschild, Hubert Serve, Thomas Oellerich, Björn Steffen, Sebastian Scheich

Blood (2024) 144 (Supplement 1): 2022.

https://doi.org/10.1182/blood-2024-207279

Published: 2024

Journal Articles

Incidence, Risk Factors, and Outcomes of Candida Bloodstream Infections in Hematological and Oncological Patients

Sebastian Wolf, Sarah Weber, Aaron Janetta, Friederike Klein, Julius C. Enssle, Michael Hogardt, Volkard A. J. Kempf, Johanna Kessel, Maria J. G. T. Vehreschild, Björn Steffen, Thomas Oellerich, Hubert Serve, Sebastian Scheich

Blood (2024) 144 (Supplement 1): 2866.

https://doi.org/10.1182/blood-2024-205960

Published: 2024

Journal Articles

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Blood (2023) 142 (Supplement 1): 2986.

https://doi.org/10.1182/blood-2023-174325

Published: 2023

Journal Articles

Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy

Blood (2023) 142 (Supplement 1): 850.

https://doi.org/10.1182/blood-2023-190851

Published: 2023

Journal Articles

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 2819.

https://doi.org/10.1182/blood-2023-178059

Published: 2023

Journal Articles

Alternative Splicing of Bcap (PIK3AP1) Enhances Oncogenic Signaling in Subsets of Activated B-Cell Diffuse Large B-Cell Lymphoma

Andy Itsara, Sebastian Scheich, Björn Häupl, Xin Yu, Thomas Oellerich, Louis M. Staudt

Blood (2022) 140 (Supplement 1): 6394–6395.

https://doi.org/10.1182/blood-2022-163619

Published: 2022

Journal Articles

Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia

Constanze Schneider, Hermes Spaink, Gabriela Alexe, Neekesh V. Dharia, Ashleigh Meyer, Delan Khalid, Sebastian Scheich, Björn Häupl, Louis M. Staudt, Thomas Oellerich, Kimberly Stegmaier

Blood (2022) 140 (Supplement 1): 4936–4937.

https://doi.org/10.1182/blood-2022-168226

Published: 2022

Journal Articles

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Blood (2022) 139 (4): 538–553.

https://doi.org/10.1182/blood.2021012081

Published: 2022

Includes: Supplemental data

Journal Articles

Impact of Body Mass Index on Patient Outcome in Acute Myeloid Leukemia Patients Receiving Intensive Induction Therapy: A Real-World Registry Experience

Blood (2021) 138 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2021-145917

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Efficacy and safety of vipor (P) in relapsed or refractory large B-cell lymphoma

The role of RhoA in diffuse large B-cell lymphoma

Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes

Characterizing the Microbiome-Immune Axis in Hematopoietic Stem Cell Recipients

Incidence, Risk Factors, and Outcomes of Candida Bloodstream Infections in Hematological and Oncological Patients

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Alternative Splicing of Bcap (PIK3AP1) Enhances Oncogenic Signaling in Subsets of Activated B-Cell Diffuse Large B-Cell Lymphoma

Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Impact of Body Mass Index on Patient Outcome in Acute Myeloid Leukemia Patients Receiving Intensive Induction Therapy: A Real-World Registry Experience

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only